Rockland Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9M Sell
78,477
-20,122
-20% -$4.69M 0.78% 37
2026
Q1
$24.1M Sell
98,599
-2,299
-2% -$535K 0.96% 30
2025
Q4
$20.9M Sell
100,898
-1,527
-1% -$302K 0.82% 39
2025
Q3
$19M Sell
102,425
-4,972
-5% -$852K 0.78% 42
2025
Q2
$16.4M Sell
107,397
-142
-0.1% -$21.8K 0.8% 42
2025
Q1
$17.8M Sell
107,539
-2,649
-2% -$414K 0.9% 38
2024
Q4
$15.9M Sell
110,188
-1,173
-1% -$182K 0.81% 39
2024
Q3
$18M Sell
111,361
-6,686
-6% -$1.07M 0.89% 39
2024
Q2
$17.3M Buy
118,047
+1,969
+2% +$293K 0.91% 36
2024
Q1
$18.4M Sell
116,078
-4,550
-4% -$724K 0.97% 36
2023
Q4
$18.9M Buy
120,628
+251
+0.2% +$38.5K 1.03% 32
2023
Q3
$18.7M Sell
120,377
-1,215
-1% -$200K 1.13% 31
2023
Q2
$20.1M Buy
121,592
+9,522
+8% +$1.54M 1.2% 24
2023
Q1
$17.4M Sell
112,070
-1,405
-1% -$227K 1.09% 28
2022
Q4
$20M Sell
113,475
-3,955
-3% -$683K 1.27% 19
2022
Q3
$19.2M Sell
117,430
-4,951
-4% -$838K 1.37% 17
2022
Q2
$21.7M Sell
122,381
-87,645
-42% -$15.6M 1.5% 16
2022
Q1
$37.2M Buy
210,026
+2,016
+1% +$343K 2.37% 7
2021
Q4
$35.6M Buy
208,010
+3,335
+2% +$546K 2.27% 8
2021
Q3
$33.1M Buy
204,675
+3,296
+2% +$562K 2.31% 10
2021
Q2
$33.2M Buy
201,379
+851
+0.4% +$141K 2.29% 9
2021
Q1
$33M Buy
200,528
+5,575
+3% +$902K 2.37% 7
2020
Q4
$30.7M Buy
194,953
+2,128
+1% +$314K 2.38% 8
2020
Q3
$28.7M Sell
192,825
-2,778
-1% -$411K 2.47% 7
2020
Q2
$27.5M Sell
195,603
-2,630
-1% -$383K 2.47% 7
2020
Q1
$26M Sell
198,233
-2,069
-1% -$294K 2.65% 5
2019
Q4
$29.2M Buy
200,302
+40,598
+25% +$5.51M 2.41% 4
2019
Q3
$21M Buy
159,704
+7,172
+5% +$945K 1.9% 9
2019
Q2
$21.2M Buy
152,532
+2,425
+2% +$336K 2.11% 8
2019
Q1
$21M Buy
150,107
+4,430
+3% +$593K 2.22% 6
2018
Q4
$18.8M Sell
145,677
-1,820
-1% -$254K 2.31% 4
2018
Q3
$20.4M Sell
147,497
-3,198
-2% -$425K 2.49% 4
2018
Q2
$18.3M Sell
150,695
-2,654
-2% -$331K 2.36% 7
2018
Q1
$19.7M Sell
153,349
-474
-0.3% -$64.1K 2.6% 4
2017
Q4
$21.5M Sell
153,823
-872
-0.6% -$121K 2.77% 4
2017
Q3
$20.1M Sell
154,695
-1,927
-1% -$255K 3.01% 3
2017
Q2
$20.7M Sell
156,622
-1,621
-1% -$207K 3.24% 2
2017
Q1
$19.7M Sell
158,243
-668
-0.4% -$79.8K 3.11% 2
2016
Q4
$18.3M Buy
158,911
+1,114
+0.7% +$129K 2.93% 3
2016
Q3
$18.6M Buy
157,797
+1,161
+0.7% +$141K 3.23% 2
2016
Q2
$19M Sell
156,636
-3,249
-2% -$369K 3.29% 2
2016
Q1
$17.3M Sell
159,885
-3,314
-2% -$343K 3.11% 2
2015
Q4
$16.8M Buy
163,199
+3,208
+2% +$323K 2.95% 3
2015
Q3
$14.9M Buy
159,991
+5,095
+3% +$493K 2.93% 3
2015
Q2
$15.1M Buy
154,896
+312
+0.2% +$31.2K 3% 3
2015
Q1
$15.6M Buy
154,584
+393
+0.3% +$40K 3.29% 1
2014
Q4
$16.1M Sell
154,191
-3,184
-2% -$336K 3.32% 2
2014
Q3
$16.8M Buy
157,375
+5,088
+3% +$528K 3.69% 2
2014
Q2
$15.9M Buy
152,287
+213
+0.1% +$21.5K 3.62% 2
2014
Q1
$14.9M Buy
152,074
+5,013
+3% +$465K 3.51% 4
2013
Q4
$13.5M Buy
147,061
+2,383
+2% +$220K 3.24% 2
2013
Q3
$12.5M Buy
144,678
+22,770
+19% +$2.04M 3.31% 3
2013
Q2
$10.5M Buy
+121,908
New +$10.3M 2.9% 5

Other funds holding JNJ

Rockland Trust's JNJ Position: Q2 2026 in Review

Rockland Trust reduced its Johnson & Johnson (JNJ) stake by 20% in Q2 2026, selling an estimated $4.69M and leaving 78,477 shares worth $19.9M. The position accounts for 0.78% of the portfolio, ranked #37.

Rockland Trust first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.2M in Q1 2022. 1,474 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rockland Trust held 78,477 shares of Johnson & Johnson worth $19.9M as of Q2 2026.
  • Rockland Trust sold 20,122 Johnson & Johnson shares in Q2 2026, an estimated $4.69M.
  • Johnson & Johnson made up 0.78% of Rockland Trust's portfolio in Q2 2026, its #37 holding.
  • Rockland Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Rockland Trust's Johnson & Johnson position peaked at $37.2M in Q1 2022.
  • 1,474 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.